Japan, Oct. 30 -- LENTIGEN TECHNOLOGY INC has got intellectual property rights for 'METHOD TO TREAT CANCER WITH ENGINEERED T CELLS.' Other related details are as follows:
Application Number: JP,2021-176625
Category (FI): C12N15/13,A61K35/17@Z,A61K35/76,A61K39/395@C,A61K39/395@E,A61K39/395@L,A61K39/395@T,A61K47/68,A61K48/00,A61P35/00,A61P35/02,A61P37/04,C07K16/28,C07K16/46,C07K19/00,C12N15/62@Z,C12N15/867@Z,C12N5/10,C12P21/08,A61K35/17
Stage: Grant (IP right document published.)
Filing Date: Oct. 28, 2021
Publication Date: Feb. 9, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....